<?xml version="1.0" encoding="UTF-8" ?><dbgapss xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="dbgapssws.1.0.xsd"><Study uid="23823" whole_study_id="22366" phs="001257" v="2" p="1" createDate="2017-03-07T10:54:51-05:00" completedByGPADate="2017-03-07T12:44:44-05:00" modDate="2020-01-21T13:21:55-05:00" maxParentChildStudyModDate="2020-01-21T13:21:55-05:00" handle="Anti_CTLA_4" num_participants="22"><StudyInfo accession="phs001257.v2.p1" parentAccession="phs001257.v2.p1"><BioProject id="PRJNA357320" entrez_id="357320" type="bp_admin_access"/><BioProject id="PRJNA357321" entrez_id="357321" type="bp_data_submission"/><StudyNameEntrez>Loss of IFN-g signaling in tumor cells associates with primary resistance to anti-CTLA-4  therapy</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>individual_sequencing</StudyType><StudyType>dna</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>U54 CA163125</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="false" is_admin_ic="false" primary="true"/></ICs><Persons><Person nedid="FUTREALPA" aid="2" auth="eRA" login="FUTREALPA" fname="ANDREW" mname="" lname="FUTREAL" email="afutreal@mdanderson.org"><Role>PI</Role><Organization>SANGER INSTITUTEUNIVERSITY OF TX MD ANDERSON CAN CTR</Organization></Person><Person aid="8" auth="virtual" fname="Lurtese" lname="Sherrell-Gardner" email="LMSherrell@mdanderson.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0014392987" aid="1" auth="cit" login="fingerma" fname="Ian" mname="Michael" lname="Fingerman" email="fingerma@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The exome sequnecing was supported by grant 5U54CA163125 from NIH to Andrew Futreal, Jennifer A. Wargo and Lynda Chin.</acknowledgement_statement><ic_specific_access_term/><DUC universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC><DUC_PDF universal_duc="Yes"><File full_url="https://dbgap.ncbi.nlm.nih.gov/aa/docs/Static_DUC_20190419.pdf" filename="Static_DUC_20190419.pdf" content-type="application/pdf"/></DUC_PDF><GSR_Access gsr_mode="unrest_access_by_timeout" gsr_mode_label="Unrestricted access (institution did not respond within six months)"/><ConsentGroup uid="2323" CGType="cg_class_DS" title="Disease-Specific (Melanoma, PUB, NPU)" name="DS-M-PUB-NPU" dac_uid="59" dac_name="NCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Melanoma.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study><Study uid="22366" whole_study_id="22366" phs="001257" v="1" p="1" createDate="2016-11-21T08:55:37-05:00" completedByGPADate="2016-11-21T09:11:55-05:00" modDate="2020-09-01T11:31:34-05:00" maxParentChildStudyModDate="2020-09-01T11:31:34-05:00" handle="Anti_CTLA_4" num_participants="22"><StudyInfo accession="phs001257.v1.p1" parentAccession="phs001257.v1.p1"><BioProject id="PRJNA357320" entrez_id="357320" type="bp_admin_access"/><BioProject id="PRJNA357321" entrez_id="357321" type="bp_data_submission"/><StudyNameEntrez>Loss of IFN-g signaling in tumor cells associates with primary resistance to anti-CTLA-4  therapy</StudyNameEntrez><StudyTypes2 calculated="Yes"><StudyType21 name="phenotype_data" chosen="No"/><StudyType21 name="analysis" chosen="No"/><StudyType21 name="individual_sequencing" chosen="Yes"><StudyType22 name="ncbi_for_sequence"/><StudyType22 name="whole_targ_exome"/></StudyType21><StudyType21 name="supporting_documents" chosen="No"/><StudyType21 name="images" chosen="No"/><StudyType21 name="molecular" chosen="No"/><StudyType21 name="subject_samples" chosen="Yes"><StudyType22 name="dna"/></StudyType21><StudyType21 name="links_to_ncbi_dbs" chosen="No"/><StudyType21 name="other_general" chosen="No"/></StudyTypes2><StudyTypes><StudyType>individual_sequencing</StudyType><StudyType>dna</StudyType><StudyType>whole_exome</StudyType><StudyType>sra</StudyType></StudyTypes><SraStorages/><Funding>U54 CA163125</Funding></StudyInfo><Authority><ICs><IC id="4" name="NCI" is_funding_ic="true" is_admin_ic="true" primary="true"/></ICs><Persons><Person nedid="FUTREALPA" aid="2" auth="eRA" login="FUTREALPA" fname="ANDREW" mname="" lname="FUTREAL" email="afutreal@mdanderson.org"><Role>PI</Role><Organization>SANGER INSTITUTEUNIVERSITY OF TX MD ANDERSON CAN CTR</Organization></Person><Person aid="8" auth="virtual" fname="Lurtese" lname="Sherrell-Gardner" email="LMSherrell@mdanderson.org"><Role>PI_ASSIST</Role><Organization/></Person><Person nedid="0010579723" aid="1" auth="cit" login="wewu" fname="Wenyu" mname="" lname="Wu" email="wwu@ncbi.nlm.nih.gov"><Role>PHENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0011559580" aid="1" auth="cit" login="stefanov" fname="Stefan" mname="Alexandrov" lname="Stefanov" email="stefanov@mail.nih.gov"><Role>GENO_CURATOR</Role><Organization>NIH</Organization></Person><Person nedid="0010170421" aid="1" auth="cit" login="strasbuj" fname="Jennifer" mname="A" lname="Strasburger" email="strasbuj@mail.nih.gov"><Role>GPA</Role><Organization>NIH</Organization></Person></Persons></Authority><Policy display-research-statement="true" display-public-summary="true" years-until-renewal="1" weeks-to-cancel-request="8" pub-embargo="none"><acknowledgement_statement>The exome sequnecing was supported by grant 5U54CA163125 from NIH to Andrew Futreal, Jennifer A. Wargo and Lynda Chin.</acknowledgement_statement><ic_specific_access_term/><DUC><File uri="dbgapssws.cgi?blob_id=22372&amp;file=get&amp;page=file" filename="DUL_Futreal_11202016.rtf" md5="b63252df588f378eea8eab6eaf289a4c" size="200622" modDate="2016-11-21T09:10:06-05:00" content-type="application/msword"/></DUC><DUC_PDF><File uri="dbgapssws.cgi?blob_id=22374&amp;file=get&amp;page=file" filename="DUL_Futreal_11202016.rtf.pdf" md5="2b6087ab65fcbcb1c4c3a41596820313" size="164690" modDate="2016-11-21T09:10:21-05:00" content-type="application/pdf"/></DUC_PDF><ConsentGroup uid="2323" CGType="cg_class_DS" title="Disease-Specific (Melanoma, PUB, NPU)" name="DS-M-PUB-NPU" dac_uid="62" dac_name="eNCI DAC" irb-approval-required="No"><Use-Restriction>Use of the data must be related to Melanoma.
Requestor agrees to make results of studies using the data available to the larger scientific community.
Use of the data is limited to not-for-profit organizations.

</Use-Restriction></ConsentGroup></Policy><SRA/><Documents/><Status uid="1" name="released" title="Released"/></Study></dbgapss>